Clicky

LIQUIDIA CORP. DL-001(LT4) News

Date Title
May 24 FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute
May 23 U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
May 21 3 Growth Companies With Insider Ownership Up To 19%
May 12 Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
Mar 14 One Liquidia Insider Raised Their Stake In The Previous Year
Mar 12 Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
Feb 24 Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
Feb 21 US Growth Stocks With High Insider Ownership Seeing Up To 48% Revenue Growth
Jan 8 Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference